Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial

CONCLUSIONS: A single subanesthetic dose of esketamine can result in lower postoperative score on subthreshold depressive symptoms compared to the Group C on POD 1, without increasing the occurrence of postoperative adverse reactions.TRIAL REGISTRATION: Registration number: Chinese Clinical Trial Registry ChiCTR2200057028. Date of registration: 26/02/2022.PMID:38658886 | DOI:10.1186/s12888-024-05753-9

Source: Cancer Control - April 24, 2024 Category: Cancer & Oncology Authors: Huanwei Wang Rigen Te Jianxing Zhang Yanbing Su Hongxia Zhou Na Guo Dongmei Chi Wan Huang Source Type: research